New signal stabilizes atherosclerotic plaques

July 31, 2013

Atherosclerosis is an inflammatory disease with accumulation of cholesterol in the vessel walls. The atherosclerotic plaque is built up throughout life and when it ruptures it leads to heart attack or stroke. T cells are important immune cells able to direct the immune response; they are present in the plaques at all stages and signal to other cells through contact or secretion of cytokines, a type of hormone-like signal molecules. In the present study the researchers have identified a cytokine produced by T cells that can stabilize atherosclerotic plaques and protect them from rupture.

The researchers made the finding when investigating a new mouse model together with scientists at Yale University and Howard Hughes Medical Institute in the United States.

"When we analyzed the mouse model the result puzzled us. The outcome was opposite to our ", says Anton Gisterå, one of the researchers who conducted the study. "We had to conduct a series of new experiments to understand what was going on, and ended up identifying the cytokine interleukin-17 as a signal that can stabilize plaques".

The possibility to pharmaceutically use this in patients to stabilize their plaques was not assessed in this study, but the findings provide important information on the role of the immune system in atherosclerosis.

"Traditionally, scientists and physicians have viewed atherosclerosis as merely a buildup of cholesterol in the arteries, and the influence of inflammation has not been fully attributed", says Göran K. Hansson, team leader of the Experimental Cardiovascular Research group at the Center for Molecular Medicine, and principal investigator of the study. "We need to explore the inflammatory pathways to find new therapies aside from lowering lipids. We have effective statin therapy, but a substantial risk of heart attacks still remains for treated individuals."

The researchers conclude that their results points toward a possible therapeutic approach to stabilize . Also, in certain patient groups treated with interleukin-17 blocking therapies for other diseases, this stabilizing pathway might be hampered, therefore these patients should be monitored carefully regarding their cardiovascular health.

Explore further: Inflammation worsens danger due to atherosclerosis

More information: 'Transforming growth factor-B signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17 dependent pathway', Anton Gisterå, Anna-Karin Robertson, John Andersson, Daniel FJ Ketelhuth, Olga Ovchinnikova, Stefan K Nilsson, Anna M Lundberg, Ming O Li, Richard A Flavell, Göran K Hansson, Science Translational Medicine, online 31 July 2013.

Related Stories

Inflammation worsens danger due to atherosclerosis

January 22, 2009

Current research suggests that inflammation increases the risk of plaque rupture in atherosclerosis. The related report by Ovchinnikova et al, "T cell activation leads to reduced collagen maturation in atherosclerotic plaques ...

Atherosclerosis: Specific microRNAs promote inflammation

March 22, 2013

(Medical Xpress)—Atherosclerosis, an inflammatory reaction, is at the root of the most common forms of cardiovascular disease. Researchers at Ludwig-Maximilians-Universitaet in Munich have now identified a microRNA that ...

Researchers discover new way to block inflammation

July 1, 2013

Researchers at NYU Langone Medical Center have discovered a mechanism that triggers chronic inflammation in Alzheimer's, atherosclerosis and type-2 diabetes. The results, published today in Nature Immunology, suggest a common ...

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.